Illumina Current Ratio 2006-2021 | ILMN

Current and historical current ratio for Illumina (ILMN) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Illumina current ratio for the three months ending June 30, 2021 was 6.08.
Illumina Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $5.31B $0.87B 6.08
2021-03-31 $5.64B $1.27B 4.45
2020-12-31 $4.48B $1.24B 3.60
2020-09-30 $4.33B $1.12B 3.88
2020-06-30 $4.19B $1.12B 3.76
2020-03-31 $4.32B $1.05B 4.10
2019-12-31 $4.45B $0.67B 6.69
2019-09-30 $4.22B $0.62B 6.82
2019-06-30 $4.16B $0.61B 6.79
2019-03-31 $4.55B $1.24B 3.66
2018-12-31 $4.49B $1.80B 2.49
2018-09-30 $4.26B $1.74B 2.46
2018-06-30 $3.34B $1.22B 2.74
2018-03-31 $3.19B $1.18B 2.71
2017-12-31 $2.98B $0.75B 4.00
2017-09-30 $2.81B $0.67B 4.22
2017-06-30 $2.64B $0.68B 3.88
2017-03-31 $2.52B $0.72B 3.49
2016-12-31 $2.32B $0.71B 3.29
2016-09-30 $2.28B $0.63B 3.62
2016-06-30 $2.14B $0.58B 3.69
2016-03-31 $2.07B $0.48B 4.31
2015-12-31 $2.10B $0.61B 3.44
2015-09-30 $2.21B $0.58B 3.79
2015-06-30 $2.24B $0.73B 3.09
2015-03-31 $2.06B $0.71B 2.90
2014-12-31 $1.89B $0.72B 2.62
2014-09-30 $1.91B $0.86B 2.23
2014-06-30 $1.62B $0.65B 2.50
2014-03-31 $1.63B $1.15B 1.42
2013-12-31 $1.62B $0.32B 5.02
2013-09-30 $1.54B $0.42B 3.67
2013-06-30 $1.65B $0.42B 3.93
2013-03-31 $1.55B $0.41B 3.78
2012-12-31 $1.79B $0.31B 5.87
2012-09-30 $1.65B $0.30B 5.43
2012-06-30 $1.66B $0.30B 5.56
2012-03-31 $1.64B $0.29B 5.59
2011-12-31 $1.55B $0.23B 6.81
2011-09-30 $1.50B $0.30B 5.06
2011-06-30 $1.62B $0.28B 5.71
2011-03-31 $1.51B $0.35B 4.38
2010-12-31 $1.26B $0.54B 2.35
2010-09-30 $1.14B $0.50B 2.28
2010-06-30 $1.09B $0.48B 2.26
2010-03-31 $1.04B $0.45B 2.33
2009-12-31 $0.98B $0.44B 2.23
2009-09-30 $1.03B $0.41B 2.50
2009-06-30 $0.98B $0.41B 2.42
2009-03-31 $0.90B $0.38B 2.34
2008-12-31 $0.87B $0.39B 2.25
2008-09-30 $0.88B $0.49B 1.78
2008-06-30 $0.51B $0.49B 1.04
2008-03-31 $0.47B $0.47B 0.99
2007-12-31 $0.56B $0.17B 3.40
2007-09-30 $0.49B $0.08B 6.16
2007-06-30 $0.45B $0.08B 5.90
2007-03-31 $0.43B $0.07B 6.36
2006-12-31 $0.19B $0.03B 5.74
2006-09-30 $0.22B $0.03B 6.60
2006-06-30 $0.20B $0.04B 5.72
2006-03-31 $0.09B $0.03B 3.43
2005-12-31 $0.08B $0.02B 3.67
2005-09-30 $0.08B $0.02B 3.87
2005-06-30 $0.07B $0.02B 4.84
2005-03-31 $0.08B $0.02B 5.16
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $61.202B $3.239B
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86